Rami S. Komrokji, Valeria Santini, Amer Methqal Zeidan, Mikkael A. Sekeres, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, Yazan F. Madanat, Maria Diez-Campelo, David Valcárcel, Anna Jonasova, Sheetal Shah, Qi Xia, Libo Sun, Shyamala Chendeal Navada, Michael R. Savona, Uwe Platzbecker. "Effect of prior treatment (tx) on the clinical activity of imetelstat (IME) in transfusion-dependent (TD) patients (pts) with erythropoiesis-stimulating agent (ESA), relapsed or refractory (R/R)/ineligible lower-risk myelodysplastic syndromes (LR-MDS).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6569